Onto Innovation

▲ Bull Case

• ◆AI capex cycle extends through FY2028+ with no correction — TSMC announces 2x CoWoS expansion; HBM4 ramp at SK Hynix and Micron accelerates; FOPLP transitions to volume production. ONTO AP revenue compounds at 25%+ CAGR through FY27; revenue reaches $1.95B in FY27.
• ◆AP TAM is larger than consensus assumes — Panel-level packaging + chiplet architecture proliferation expand AP process control TAM from $3–5B to $8–12B by 2028. ONTO captures $1B+ in AP revenue with operating leverage to 35% EBIT margins.
• ◆Multiple re-rating sticks — Process-control multiples remain at AI-era highs (current KLA forward EV/EBITDA ~34x); ONTO trades to Camtek-parity multiples justifying $310–$360 fair value (+19% to +38% from $261).

▼ Bear Case

• ◆WFE correction in FY27 — Historical base rate is one cycle correction per 4–5 years; AI capex pull-forward completed by mid-FY26; ONTO revenue declines -12% in FY27. Gross margin compresses to 49–50% on negative operating leverage; EBIT margin to 19%.
• ◆AI capex disappoints in 2027 — Hyperscaler enterprise-AI monetization underwhelms; Microsoft + Google + Amazon coordinate ~20%+ capex cuts; TSMC delays CoWoS expansion 12–18 months; ONTO bookings collapse 30% in 2-quarter window.
• ◆KLA enters advanced packaging lithography — With 10x ONTO's revenue and dominant process-control market share, KLA mobilizes its R&D budget; customer qualifications at TSMC and Samsung announced within 12 months. ONTO's AP litho revenue at risk of -30 to -40% by FY29.

“The Wall Street debate is not about whether ONTO has a good business — that is consensus. The debate is whether the company should be valued like: (A) A pure-play AI-AP beneficiary (Camtek-parity multiples ~30x P/E), justifying $300+ price targets, OR (B) A mid-tier cyclical semicap equipment maker (LRCX-style ~20x P/E), justifying $180–$220, OR (C) A KLA-quality moat business (~35x P/E), justifying $260–$310. The consensus Strong Buy rating with $309 average PT suggests the Street has settled on a midpoint between (A) and (C). My triangulated framework lands closer to (B)–(C) midpoint at ~$195–$235 — modestly below current price.”

• ◆TSMC CoWoS capacity expansion announcement (next: TSMC Q3 2026 earnings/Investor Day) — Direct read on ONTO's largest AP revenue driver
• ◆Q2/Q3 2026 ONTO earnings + guidance — Bookings momentum + AP-mix progression; gross margin >53% would validate the bull-case margin path
• ◆Firefly 2.0 product announcement (expected 2026–2027) — Refreshes AP litho technology leadership; ASP uplift catalyst
• ◆HBM4 production qualification at SK Hynix / Micron (2026) — Expands Iris XRF metrology revenue 30–50% from HBM segment
• ◆Domestic fab qualifications (TSMC Arizona, Intel Ohio, Micron Idaho) — Geographic diversification proof point
• ◆Potential tuck-in acquisition — $650M net cash creates AP-adjacent M&A optionality (e.g., hybrid bonding metrology)

• ◆WFE cycle correction in FY27 (HIGH net risk) — Cyclical inevitability; AI capex extending the cycle but not eliminating it. Fair-value impact: -25–35%
• ◆AI capex slowdown / 'AI winter' (HIGH-MEDIUM) — Hyperscaler capex guidance cuts; CoWoS demand softens. Fair-value impact: -25–40%
• ◆TSMC customer concentration (MEDIUM-HIGH) — ~25–30% of revenue from a single customer; CoWoS pause = disproportionate ONTO impact
• ◆KLA competitive entry in AP (MEDIUM, 5-yr horizon) — Most likely thesis-killer event. ONTO's 3–5 year window to entrench is the critical execution period
• ◆China export-control escalation (MEDIUM) — Remaining $90–110M China revenue exposed; manageable but not zero
• ◆Taiwan geopolitical (LOW-prob, SEVERE-impact) — Tail risk; appropriate to monitor not size
• ◆Valuation multiple compression (MEDIUM, now relevant) — Current multiples assume sustained AI-cycle premium; reversion to LRCX-style ~17x EBITDA = -40% downside